| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 0.0001 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.24 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.47 | 0.0004 |